Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Agence régionale de santé Ile de France | UNKNOWN |
| UNION NATIONALE DE FAMILLES ET AMIS DE PERSONNES MALADES ET/OU HANDICAPÉES PSYCHIQUES | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Prospective longitudinal uncontrolled multicenter study, with cohort follow-up, focusing on patients, professionals, relatives and structures evolution during the implementation of recovery based intervention.
This is a hybrid efficacy-implementation Type I recovery based interventional study based on a multicenter follow-up of a cohort of 300 patients with severe and persistent mental disorders (60 patients per center). The evolution of concepts and means of evaluation now allow a precise description of the mechanisms of recovery in all the diversity of its expression among patients, their entourages and the psychiatric facilities.
In the present study, the investigators aim to characterize simultaneously the patients' trajectories and the evolution of the care facilities and their professionals with respect to the principles of recovery. This double exploration should allow to build theoretical and practical references for the extension of this approach to other centers in France.
The study considers a dual timeline for data collection:
The intervention consists in a follow-up of the patients and their relatives by a psychiatric nurse and a social worker during 12 months. Both professionals, trained to rehabilitation and recovery principles, will focus on the patient's needs and goals in order to improve the outcome, quality-of-life and clinical status.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Patient group (single group) | Experimental | 300 Patients involved in the recovery process. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Patient group/Passvers | Behavioral | Passvers intervention aims at :
Passvers also aims at :
|
| Measure | Description | Time Frame |
|---|---|---|
| Patient self rating of recovery support by caregivers T0 | 5-item short version of INSPIRE measure (Brief INSPIRE), range from 5 to 25, 25 corresponds to maximal support | baseline |
| Patient self rating of recovery support by caregivers T12 | 5-item short version of INSPIRE measure (Brief INSPIRE), range from 5 to 25, 25 corresponds to maximal support | 1 year |
| Patient self rating of recovery support by caregivers and structure T0 | Recovery Self-Assessment (RSA-R), range from 32 to 160, higher values correspond to more perceived help | baseline |
| Patient self rating of recovery support by caregivers and structure T12 | Recovery Self-Assessment (RSA-R), range from 32 to 160, higher values correspond to more perceived help | 1 year |
| Patient functioning T0 | Personal and Social Performance scale (PSP), range 0-100, 100 corresponds to better functioning | baseline |
| Patient functioning T12 | Personal and Social Performance scale (PSP), range 0-100, 100 corresponds to better functioning | 1 year |
| Patient functioning T24 | Personal and Social Performance scale (PSP), range 0-100, 100 corresponds to better functioning | 2 years |
| Measure | Description | Time Frame |
|---|---|---|
| Professional's Recovery knowledge on patients T0 | Recovery knowledge inventory (RKI), range 20-100, higher values correspond to better knowledge on recovery processes | baseline |
| Professional's Recovery knowledge on patients T12 |
| Measure | Description | Time Frame |
|---|---|---|
| Structure recovery orientation T0 | Recovery Self-Assessment Services (RSA-R Services), range 32-160, higher values correspond to more pronounced recovery orientation of the structure | baseline |
| Structure recovery orientation T24 |
Inclusion Criteria:
Presence of a severe and persistent mental disorder among the following ICD10 compliant diagnostic categories:
Presence of an indication for inclusion in the rehabilitation project identified by the treating psychiatrist and endorsed in the inclusion session by the PASSVers staff.
Written consent from the patient or his/her legal representative to participate in the study.
Exclusion Criteria:
Presence of an not stabilized or progressive organic neurological pathology, neurodegenerative disease
Psychological or behavioral disorders mainly related to addictions with substances
Psychiatric disorders secondary to an organic pathology that is not stabilized or that is evolving
The following psychiatric situations are reasons for non-inclusion in the absence of an argued and collegial reassessment (the reason being that, although PASSVers2 must be considered as a first intention proposal in many situations meeting the inclusion criteria, it cannot intervene or be thought of as a "solution" to certain complex situations):
Foreseeable departure from the geographic area, not allowing for certainty of further evaluation
Refusal of the patient to be followed by a social-health team (i.e. refusal of care or refusal of a dialogue on social aspects and projects).
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Virginie Bulot, MD | Contact | 33 1 39 63 90 11 | vbulot@ch-versailles.fr | |
| Eric Brunet-Gouet, MD PhD | Contact | ebrunet@ch-versailles.fr |
| Name | Affiliation | Role |
|---|---|---|
| Christine Passerieux, Prof | CH Versailles | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Centre Hospitalier d'Argenteuil, secteurs 95G05, 95G06, 95G13, | Argenteuil | France |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| Background | Bazin, N. Les suivis sociosanitaires des personnes présentant un trouble mental sévère et persistant : expérimentation PASSVers à Versailles. Inf. Psychiatr. 95, 509-513 (2019). |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D001523 | Mental Disorders |
| D012559 | Schizophrenia |
| D001714 | Bipolar Disorder |
| D001321 | Autistic Disorder |
| ID | Term |
|---|---|
| D019967 | Schizophrenia Spectrum and Other Psychotic Disorders |
| D000068105 | Bipolar and Related Disorders |
| D019964 | Mood Disorders |
| D000067877 | Autism Spectrum Disorder |
Not provided
Not provided
Prospective longitudinal uncontrolled multicenter study, with cohort follow-up, focusing on patients, professionals, relatives and structures.
Not provided
Not provided
Not provided
Not provided
|
| Patient self rating of quality of life T0 | Shortened quality of life questionnaire (SQoL-18), range 18-90, higher values correspond to better quality of life | baseline |
| Patient self rating of quality of life T12 | Shortened quality of life questionnaire (SQoL-18), range 18-90, higher values correspond to better quality of life | 1 year |
| Patient self rating of quality of life T24 | Shortened quality of life questionnaire (SQoL-18), range 18-90, higher values correspond to better quality of life | 2 years |
| Psychotic symptoms T0 | Positive and negative syndrome scale (PANSS), range 30-210, higher values correspond to higher symptoms levels | baseline |
| Psychotic symptoms T12 | Positive and negative syndrome scale (PANSS), range 30-210, higher values correspond to higher symptoms levels | 1 year |
| Depression T0 | Psychiatric symptoms scales rated by the clinicians (CDSS), range 0-27, higher values correspond to higher depressive symptoms | baseline |
| Depression T12 | Psychiatric symptoms scales rated by the clinicians (CDSS), range 0-27, higher values correspond to higher depressive symptoms | 1 year |
| Clinical outcome T0: Clinically significant events | Record of occurrences (boolean) and dates of any clinical event (hospitalizations, self-harming behavior) occurring during the course of the illness | baseline |
| Clinical outcome T12: Clinically significant events | Record of occurrences (boolean) and dates of any clinical event (hospitalizations, self-harming behavior) occurring during the course of the illness | 1 year |
| Patient self rating of recovery T0 | Questionnaire about the process of recovery (QPR), range from 22 to 110, higher values correspond to better recovery | baseline |
| Patient self rating of recovery T12 | Questionnaire about the process of recovery (QPR), range from 22 to 110, higher values correspond to better recovery | 1 year |
| Patient self rating of recovery T24 | Questionnaire about the process of recovery (QPR), range from 22 to 110, higher values correspond to better recovery | 2 years |
Recovery knowledge inventory (RKI), range 20-100, higher values correspond to better knowledge on recovery processes
| 1 year |
| Professional's Recovery opinions on patients T0 | Practitioners' Beliefs, Goals and Practices in Psychiatric Rehabilitation (PBGP), range 26-104, higher values correspond to better views on patients recovery | baseline |
| Professional's Recovery opinions on patients T12 | Practitioners' Beliefs, Goals and Practices in Psychiatric Rehabilitation (PBGP), range 26-104, higher values correspond to better views on patients recovery | 1 year |
| Stigmatization T0 | Internalized stigma of mental illness: self-stigma (ISMI), range 29-116, higher values correspond to worse stigmatization perception | baseline |
| Stigmatization T12 | Internalized stigma of mental illness: self-stigma (ISMI), range 29-116, higher values correspond to worse stigmatization perception | 1 year |
| Perceived needs T0 | Perceived needs scale (ELADEB), Composite measure of perceived difficulty in meeting needs and needs of help | baseline |
| Perceived needs T12 | Perceived needs scale (ELADEB), Composite measure of perceived difficulty in meeting needs and needs of help | 1 year |
| Goal achievement T12 | Goal achievement scale (GAS), range -2 to +2, higher values correspond to better achievement of one specific goal | 1 year |
| Metacognitive strategies T0 | Versailles Metacognitive Strategies Evaluation Questionnaire (V-MSEQ), range 25-175, higher values correspond to better metacognitive strategies | baseline |
| Sleep T0 | Patient self rating of sleep (1 item Pittsburgh sleep quality index PSQI), range 1-4, lower values correspond to better sleep quality | baseline |
| Sleep T12 | Patient self rating of sleep (1 item Pittsburgh sleep quality index PSQI), range 1-4, lower values correspond to better sleep quality | 1 year |
| Medication adherence T0 | Medication Adherence Rating Scale (MARS), range 5-25, lower values correspond to better adherence to treatment | baseline |
| Medication adherence T12 | Medication Adherence Rating Scale (MARS), range 5-25, lower values correspond to better adherence to treatment | 1 year |
| Illness severity T0 | Clinical Global Impressions Scale (CGI-S), range 1-7, higher values correspond to more severe illness | baseline |
| Illness severity T12 | Clinical Global Impressions Scale (CGI-S), range 1-7, higher values correspond to more severe illness | 1 year |
| Cognitive disability T0 | Cognitive processes involved in disability in schizophrenia scale (CPSD), range 0-78, higher values correspond to better cognitive functioning | baseline |
| Cognitive disability T12 | Cognitive processes involved in disability in schizophrenia scale (CPSD), range 0-78, higher values correspond to better cognitive functioning | 1 year |
| Entourage assessment of structure recovery orientation T0 | Recovery Self-Assessment Significant other version (RSA-R entourage), range 40-200, higher values correspond to better recovery orientation | baseline |
| Entourage assessment of structure recovery orientation T12 | Recovery Self-Assessment Significant other version (RSA-R entourage), range 40-200, higher values correspond to better recovery orientation | 1 year |
Recovery Self-Assessment Services (RSA-R Services), range 32-160, higher values correspond to more pronounced recovery orientation of the structure
| 2 years |
| Implementation fidelity T0 | Professional ratings of Passvers fidelity scale, range 0-92, higher values correspond to better implementation | baseline |
| Implementation fidelity T24 | Professional ratings of Passvers fidelity scale, range 0-92, higher values correspond to better implementation | 2 years |
| Hôpital Sainte Anne - GHU Paris Psychiatrie & Neurosciences, secteur G75015 | Paris | France |
|
| Centre Hospitalier de Plaisir, secteur 78G16, CMP de Rambouillet | Rambouillet | France |
|
| Etablissement de Santé Mentale de Rueil-Malmaison, Groupe MGEN, secteur 92G13, CMP de Rueil-Malmaison | Rueil-Malmaison | France |
|
| Centre Hospitalier de Versailles, secteur 78G17, Centre Bleuler, Versailles | Versailles | France |
|
| D002659 | Child Development Disorders, Pervasive |
| D065886 | Neurodevelopmental Disorders |